Actively Recruiting
PIERS and BIS, sFIT:PIGF, Adrenomedullin
Led by Suez Canal University · Updated on 2026-04-23
48
Participants Needed
1
Research Sites
739 weeks
Total Duration
On this page
Sponsors
S
Suez Canal University
Lead Sponsor
U
University of Malaya
Collaborating Sponsor
AI-Summary
What this Trial Is About
Pre-eclampsia, more than being proteinuric gestational hypertension alone, is a state of exaggerated systemic inflammation and remains a leading direct cause of maternal morbidity and mortality worldwide.1 Standardization of antenatal and postnatal assessment and surveillance of pre-eclampsia with protocols that recognize the systemic inflammatory model of preeclampsia have been associated with reduced maternal morbidity.
CONDITIONS
Official Title
PIERS and BIS, sFIT:PIGF, Adrenomedullin
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnancy at any stage (all three trimesters)
- Diagnosis of frank eclampsia
- Suspected pre-eclampsia expected to progress to frank eclampsia
You will not qualify if you...
- Presence of neurological conditions like epilepsy that affect EEG
- Medical conditions such as hypoglycemia that can alter EEG readings
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical Ethics Committee, University Malaya Medical Centre
Kuala Lumpur, Malaysia
Actively Recruiting
Research Team
A
Ashraf Dahaba, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here